Skip to main content

Our Therapies

About us

About us

Our "About us" is about "You"

At Medtronic, we are committed to empowering and supporting you, so you can manage type 1 diabetes on your own terms.

Portfolio

We’ve developed a robust portfolio of life-transforming technologies that leverage data to deliver personalized insights, so you can take on each day with confidence.

Expertise

With our comprehensive, flexible offerings, our empathetic service and support, you can live fully in the moment. We’re working to help you manage your type 1 diabetes, our way.

References

  1. Medtronic data on file: MiniMed ™ 780G data uploaded voluntarily by 12.870 users in EMEA to CareLink™ Personal, from 27 August 2020 to 22 July 2021. Mean 80% TIR reached by 1.784 users using MiniMed ™ 780G with recommended settings of 2 hours active insulin time and 100 mg/dL (5.5 mmol/L) as glucose target for at least 90% of the time.
  • 1.Medtronic data on file: MiniMed ™ 780G data uploaded voluntarily by 12.870 users in EMEA to CareLink™ Personal, from 27 August 2020 to 22 July 2021. Mean 80% TIR reached by 1.784 users using MiniMed ™ 780G with recommended settings of 2 hours active insulin time and 100 mg/dL (5.5 mmol/L) as glucose target for at least 90% of the time.
  • * Smart CGM predicts future high and low sensor glucose events up to 1 hour in advance and provides access to additional algorithms and insights that can inform users of clinically relevant glucose patterns. Please refer to IFU.
  • ** Smart Insulin pen connects to a mobile app to provide dosing calculations, reminders and CGM system integration. Please refer to IFU.